In this episode, Tzu-Hao (Howard) Lee, MD; Tatyana Kushner, MD, MSCE; and patient advocate Andrew Reynolds discuss hepatitis C virus (HCV) care in men who have sex with men and pregnant people, including:

• HCV disease burden in the United States
• Screening recommendations
• Strategies to overcome barriers to HCV screening
• Treatment recommendations, including simplified treatment guidance and considerations for pregnant people
• Strategies to improve treatment uptake

Presenters:

Tzu-Hao (Howard) Lee, MD
Assistant Professor
Section of Gastroenterology and Hepatology, Department of Medicine
Division of Abdominal Transplant, Department of Surgery
Baylor College of Medicine
Houston, Texas

Tatyana Kushner, MD, MSCE
Associate Professor
Division of Gastroenterology/Hepatology
Department of Obstetrics & Gynecology
Weill Cornell Medicine
New York, New York

Andrew Reynolds
Director, Health of People Who Use Drugs
San Francisco AIDS Foundation
San Francisco, California

To access all of our new podcast episodes, subscribe to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify. 

Link to full program:
https://bit.ly/4j973TN

Downloadable slides:
https://bit.ly/4gXuBcu

In this episode, Sonal Kumar, MD, MPH, discusses key findings from primary biliary cholangitis (PBC) studies presented at AASLD 2024, including:

• ELATIVE, a phase III trial of elafibranor for PBC
• RESPONSE, a phase III trial of seladelpar for PBC
• ASSURE, another phase III trial of seladelpar for PBC

Presenter:
Sonal Kumar, MD, MPH
Director, Clinical Gastroenterology and Hepatology
Assistant Professor of Medicine
Weill Cornell Medical College
New York, New York

Link to full program:
https://bit.ly/41tvSDu

Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

Listen in as Stephen Cantrill, MD, FACEP; Rajesh T. Gandhi, MD; and Payal K. Patel, MD, MPH, FIDSA, discuss current trends in and risk factors for progression to severe COVID-19, including for those for whom COVID-19 is not their primary concern when presenting to the emergency department (ED). Key topics of discussion include:

• How to complete a comprehensive patient workup in the ED
• Considerations regarding pulse oximetry
• Risk stratification—what places patients at higher risk of severe disease?
• A detailed patient case to illustrate key takeaways

Presenters:

Stephen Cantrill, MD, FACEP​
Associate Director and Medical Director (Retired) ​
Department of Emergency Medicine​
Denver Health Medical Center​
Associate Professor ​
Department of Emergency Medicine​
University of Colorado Health Sciences Center​
Denver, Colorado

Rajesh T. Gandhi, MD​
Massachusetts General Hospital​
Professor of Medicine​
Harvard Medical School​
Boston, Massachusetts

Payal K. Patel, MD, MPH, FIDSA​
Systemwide Director of Antimicrobial Stewardship​
Associate Professor, Division of Infectious Diseases​
Intermountain Health​
Salt Lake City, Utah

Link to full program:
https://bit.ly/4fs7Hcb

Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

In this episode, Stacey B. Trooskin, MD, PhD, MPH, Mark S. Sulkowski, MD, FIDSA, FAASLD, and Ronni Marks discuss hepatitis C virus (HCV) screening and treatment, focusing on people who use drugs, and highlight the following topics:

• Screening recommendations
• Strategies to improve HCV screening
• HCV testing
• Treatment goals
• Strategies to improve HCV treatment uptake

Presenters:

Stacey B. Trooskin, MD, PhD, MPH
Executive Medical Officer
Mazzoni Center
Faculty, University of Pennsylvania
Perelman School of Medicine
Philadelphia, Pennsylvania

Mark S. Sulkowski, MD, FIDSA, FAASLD
Professor of Medicine
Director, Division of Infectious Diseases Johns Hopkins Bayview Medical Center
Johns Hopkins University School of Medicine
Baltimore, Maryland

Ronni Marks
Founder/Director, The Hepatitis C Mentor and Support Group (HCMSG)
Patient Advocate
New York, New York

Link to full program:
https://bit.ly/4grbwPT

Listen in as Stephen Cantrill, MD, FACEP; Rajesh T. Gandhi, MD; and Payal K. Patel, MD, MPH, FIDSA, discuss best practices in treating patients hospitalized with mild to moderate COVID-19, including:

• Current guidelines from the Infectious Diseases Society of America and National Institutes of Health
• How to optimize therapy selection based on patient risk factors, including key data supporting best practices
• A detailed patient case to illustrate key takeaways

Presenters:

Stephen Cantrill, MD, FACEP​
Associate Director and Medical Director (Retired) ​
Department of Emergency Medicine​
Denver Health Medical Center​
Associate Professor ​
Department of Emergency Medicine​
University of Colorado Health Sciences Center​
Denver, Colorado

Rajesh T. Gandhi, MD​
Massachusetts General Hospital​
Professor of Medicine​
Harvard Medical School​
Boston, Massachusetts

Payal K. Patel, MD, MPH, FIDSA​
Systemwide Director of Antimicrobial Stewardship​
Associate Professor, Division of Infectious Diseases​
Intermountain Health​
Salt Lake City, Utah

Link to full program:
https://bit.ly/4fs7Hcb

Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

Clinical gaps in the treatment of pruritus in primary biliary cholangitis (PBC) remain. In this episode, taken from a recent symposium, Marlyn J. Mayo, MD; Stuart C. Gordon, MD; and Pam Rivard, RN, a person living with PBC, discuss emerging therapies currently in clinical trials for the management of this disease that can dramatically affect patients’ quality of life.

Listen as they discuss:

• Gaps in current management
• Patient perspectives: why we should not dismiss itching as an underlying psychologic problem
• PPAR agonists and how they affect pruritus
• BEZURSO and FITCH
• ELATIVE
• ENHANCE and RESPONSE
• IBATs (inhibitors of bile acid transport)
• GLIMMER
• Common questions

Presenters:

Marlyn J. Mayo, MD
Professor of Internal Medicine
Division of Digestive & Liver Diseases
UT Southwestern Medical Center
Dallas, Texas

Stuart C. Gordon, MD
Professor of Medicine
Wayne State University School of Medicine
Director, Division of Hepatology
Henry Ford Health
Detroit, Michigan

Pam Rivard, RN
Person living with PBC

Link to full program:
https://bit.ly/3Dnfb2E

Although there is currently no FDA-approved treatment for pruritus in primary biliary cholangitis (PBC), symptoms can be mitigated with nonpharmacologic or pharmacologic agents. In this episode, Marlyn J. Mayo, MD; Stuart C. Gordon, MD; and Pam Rivard, RN, a person living with PBC, discuss the clinical management of pruritus in PBC, including:

• Pruritus assessment tools
• Optimal use of tools, including frequency of assessment
• Current management of pruritus
• Nonpharmacologic interventions
• Pharmacologic agents
• Strategies to optimize assessment and management of pruritus
• Collaborative care
• Development of a treatment plan
• Ongoing assessment and adjustment of therapy
• Resources and support for patients

Presenters:

Marlyn J. Mayo, MD
Professor of Internal Medicine
Division of Digestive & Liver Diseases
UT Southwestern Medical Center
Dallas, Texas

Stuart C. Gordon, MD
Professor of Medicine
Wayne State University School of Medicine
Director, Division of Hepatology
Henry Ford Health
Detroit, Michigan

Pam Rivard, RN
Person living with PBC

Link to full program:
https://bit.ly/3Dnfb2E

In this episode, Marlyn J. Mayo, MD; Stuart C. Gordon, MD; and Pam Rivard, RN, a person living with primary biliary cholangitis (PBC), discuss the burden of pruritus in PBC and the impact it has on quality of life, including both physical and mental health, from a patient’s perspective.

Presenters:

Marlyn J. Mayo, MD
Professor of Internal Medicine
Division of Digestive & Liver Diseases
UT Southwestern Medical Center
Dallas, Texas

Stuart C. Gordon, MD
Professor of Medicine
Wayne State University School of Medicine
Director, Division of Hepatology
Henry Ford Health
Detroit, Michigan

Pam Rivard, RN
Person living with PBC

Link to full program:
https://bit.ly/4gDGDaB